{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:14:18Z","timestamp":1780402458012,"version":"3.54.1"},"reference-count":83,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.revmed.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:19:44Z","timestamp":1773836384000},"page":"307-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymphoprolif\u00e9rations T, \u00e9pid\u00e9miologie, physiopathologie et diagnostic"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-9947","authenticated-orcid":false,"given":"Lucas","family":"Pacoureau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Placais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0366-9685","authenticated-orcid":false,"given":"Aude","family":"Mausol\u00e9o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2857-3515","authenticated-orcid":false,"given":"Virginie","family":"Baltes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lazure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4942-8660","authenticated-orcid":false,"given":"Fanny","family":"Urbain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-8516","authenticated-orcid":false,"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-617X","authenticated-orcid":false,"given":"Nicolas","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.01.004_bib0420","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2024-205820","article-title":"Delays to diagnosis of peripheral t-cell lymphoma and clinical utility of molecular profiling: a UK multicentre real-world study","volume":"144","author":"Boot","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0425","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2352-3026(24)00102-9","article-title":"Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study","volume":"11","author":"Dupuis","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0430","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2026.01.004_bib0435","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0440","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0445","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004\u20132014: sub-type analyses from the UK's Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.revmed.2026.01.004_bib0450","series-title":"Epidemiology and prognosis of T-cell lymphoma. T-cell lymphomas","first-page":"25","author":"Wang","year":"2013"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2026.01.004_bib0455","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/annonc\/11.suppl_1.S63","article-title":"Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications","volume":"11","author":"Naresh","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0460","first-page":"396","article-title":"Phenotypic analysis of peripheral T cell lymphoma among the Japanese","volume":"43","author":"Nakamura","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.revmed.2026.01.004_bib0465","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2026.01.004_bib0470","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11899-024-00727-w","article-title":"Update on T-cell lymphoma epidemiology","volume":"19","author":"Chen","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.revmed.2026.01.004_bib0480","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov\/index.html [accessed April 18, 2025]."},{"key":"10.1016\/j.revmed.2026.01.004_bib0485","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0490","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973\u20132002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0495","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0500","first-page":"100126","article-title":"Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia","volume":"10","author":"Yoon","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.revmed.2026.01.004_bib0505","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2006-06-031948","article-title":"Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0510","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jncimonographs\/lgu012","article-title":"Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Wang","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.revmed.2026.01.004_bib0515","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0520","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2026.01.004_bib0525","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3390\/cancers13061414","article-title":"EBV and the pathogenesis of NK\/T cell lymphoma","volume":"13","author":"Montes-Mojarro","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.revmed.2026.01.004_bib0530","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00126334-200104010-00015","article-title":"Risk of T-cell lymphomas in persons with AIDS","volume":"26","author":"Biggar","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.revmed.2026.01.004_bib0535","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bjc.2013.294","article-title":"Risk of lymphoma subtypes after solid organ transplantation in the United States","volume":"109","author":"Clarke","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.revmed.2026.01.004_bib0540","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.revmed.2020.05.015","article-title":"[Peripheral T cell lymphomas: diagnosis and treatment]","volume":"41","author":"Galtier","year":"2020","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2026.01.004_bib0545","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients","volume":"86","author":"Lachenal","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2026.01.004_bib0550","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0555","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0560","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and S\u00e9zary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0565","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.25577","article-title":"Mycosis fungoides and S\u00e9zary syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0570","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta T-cell lymphomas","volume":"94","author":"Foppoli","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0575","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019\u00c9tude des Lymphomes de l\u2019Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0580","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.revmed.2012.07.014","article-title":"Le syndrome d\u2019activation lymphohistiocytaire de l\u2019adulte","volume":"34","author":"Michot","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2026.01.004_bib0585","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00277-012-1644-6","article-title":"Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma","volume":"92","author":"Xie","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0590","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.revmed.2021.06.013","article-title":"Neuropathies p\u00e9riph\u00e9riques associ\u00e9es aux syndromes lymphoprolif\u00e9ratifs\u00a0: spectre clinique et d\u00e9marche diagnostique","volume":"42","author":"Pacoureau","year":"2021","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2026.01.004_bib0595","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archderm.140.9.1057","article-title":"Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas","volume":"140","author":"Tancr\u00e8de-Bohin","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0600","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.semnuclmed.2022.11.001","article-title":"PET\/CT in non-Hodgkin lymphoma: an update","volume":"53","author":"Zanoni","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.revmed.2026.01.004_bib0605","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1182\/blood-2017-11-764357","article-title":"Novel insights into the pathogenesis of T-cell lymphomas","volume":"131","author":"Van Arnam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0610","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2026.01.004_bib0615","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0620","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2026.01.004_bib0625","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.01.004_bib0630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0635","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2009-04-216671","article-title":"B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0640","first-page":"841","article-title":"[Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma]","volume":"31","author":"Couronn\u00e9","year":"2015","journal-title":"Med Sci"},{"key":"10.1016\/j.revmed.2026.01.004_bib0645","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.humpath.2005.05.008","article-title":"CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry","volume":"36","author":"Yuan","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0650","doi-asserted-by":"crossref","first-page":"100875","DOI":"10.1016\/j.modpat.2025.100875","article-title":"Follicular helper T-cell lymphomas with Epstein-Barr virus-positive neoplastic cells: a rare scenario with diagnostic implications","volume":"38","author":"Burroni","year":"2025","journal-title":"Mod Pathol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0655","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2026.01.004_bib0660","doi-asserted-by":"crossref","first-page":"e70181","DOI":"10.1002\/hem3.70181","article-title":"Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database","volume":"9","author":"Grange","year":"2025","journal-title":"HemaSphere"},{"key":"10.1016\/j.revmed.2026.01.004_bib0665","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2014-07-584953","article-title":"Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels","volume":"124","author":"Bossard","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0670","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.3390\/cancers13184535","article-title":"Peripheral T-cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment","volume":"13","author":"Pileri","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.revmed.2026.01.004_bib0675","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0680","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2016-08-692566","article-title":"Peripheral T-cell lymphoma, not otherwise specified","volume":"129","author":"Broccoli","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0685","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK\u2212 anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0690","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-3-319-99716-2_6","article-title":"Anaplastic large cell lymphoma: contemporary concepts and optimal management","volume":"176","author":"Shustov","year":"2019","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.revmed.2026.01.004_bib0695","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.semdp.2019.12.002","article-title":"Pathology and genetics of anaplastic large cell lymphoma","volume":"37","author":"Leventaki","year":"2020","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0705","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0710","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0715","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0720","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.revmed.2026.01.004_bib0725","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/v17101333","article-title":"HTLV-1 and ATLL: epidemiology, oncogenesis, and opportunities for community-informed research in the United States","volume":"17","author":"Altieri","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.revmed.2026.01.004_bib0730","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0735","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428199809057597","article-title":"Adult T-cell leukemia\/lymphoma in London: clinical experience of 21 cases","volume":"31","author":"Pawson","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2026.01.004_bib0740","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1\u2013related ATLL in an area of prevalence in the United States","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2026.01.004_bib0745","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.annder.2018.01.049","article-title":"Cutaneous presentation of adult T-cell leukemia\/lymphoma (ATLL). Single-center study on 37 patients in metropolitan France between 1996 and 2016","volume":"145","author":"Hurabielle","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0750","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0755","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1182\/blood.V109.11.4598.BLDWK","article-title":"Maslak P. Adult T-cell leukemia\/lymphoma","volume":"109","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0760","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/viro.1999.9685","article-title":"Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein","volume":"257","author":"Mesnard","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.revmed.2026.01.004_bib0765","first-page":"198","article-title":"Clinicopathological features of adult T-cell leukemia\/lymphoma with HTLV-1\u2013infected Hodgkin and Reed-Sternberg\u2013like cells","volume":"5","author":"Karube","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2026.01.004_bib0770","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2026.01.004_bib0775","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.revmed.2026.01.004_bib0780","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","article-title":"Treatment and survival among 1594 patients with ATL","volume":"126","author":"Katsuya","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0785","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2026.01.004_bib0790","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2026.01.004_bib0795","first-page":"6097","article-title":"Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene","volume":"7","author":"Liang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.revmed.2026.01.004_bib0800","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1182\/blood-2005-06-2421","article-title":"SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling","volume":"107","author":"Honorat","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0805","doi-asserted-by":"crossref","first-page":"68734","DOI":"10.18632\/oncotarget.11930","article-title":"Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes","volume":"7","author":"M\u00e9lard","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.revmed.2026.01.004_bib0810","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-02-768234","article-title":"Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)","volume":"130","author":"Park","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0815","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0820","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","article-title":"PLCG1 mutations in cutaneous T-cell lymphomas","volume":"123","author":"Vaqu\u00e9","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2026.01.004_bib0825","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.revmed.2026.01.004_bib0415","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2009-04-216671","article-title":"B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:57:10Z","timestamp":1780401430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0248866326000068"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.01.004","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoprolif\u00e9rations T, \u00e9pid\u00e9miologie, physiopathologie et diagnostic","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}